NXN-188, a selective nNOS inhibitor and a 5-HT1B/1D receptor agonist, inhibits CGRP release in preclinical migraine models - Bhatt, D K; Gupta, S; Jansen-Olesen, I (Cephalalgia, 2013)
et al.